Medicine Description insulin-h-mix 30%
Insulin H Mix is a medication that combines two types of insulin: a short-acting insulin (neutral human insulin) and an intermediate-acting insulin (insulin isophane). The short-acting component quickly facilitates the uptake of glucose from the bloodstream into various cells, particularly muscle and adipose tissue, thereby lowering blood sugar levels shortly after eating. The intermediate-acting component provides a more sustained release of insulin, helping to maintain glucose control over a longer duration. Together, these two components optimize glycemic control by mimicking the physiological release patterns of insulin in response to meals and during fasting states.
Indications and Uses of Insulin H Mix
- Management of hyperglycemia in adults and children with Type 1 diabetes mellitus.
- Control of blood sugar levels in adults with Type 2 diabetes mellitus, especially those requiring both basal and prandial insulin.
- Adjunct therapy for individuals with diabetes who cannot achieve adequate glycemic control with oral hypoglycemic agents alone.
Side Effects of Insulin H Mix
- Hypoglycemia (low blood sugar), which may cause symptoms such as dizziness, sweating, and confusion.
- Weight gain due to increased uptake of glucose and calories.
- Injection site reactions, including redness, swelling, or itching.
- Allergic reactions, which may manifest as rash, itching, or difficulty breathing.
- Insulin resistance over time, potentially necessitating dose adjustments.
Storage and Handling
Insulin H Mix should be stored in a refrigerator at temperatures between 2°C and 8°C (36°F and 46°F). Once in use, it can be kept at room temperature for a limited time, away from direct heat and sunlight. It’s crucial to avoid freezing the product.
Patient Advice and Precautions
Patients should be educated on recognizing symptoms of hypoglycemia and how to treat it promptly. Regular blood glucose monitoring is essential to avoid both hyperglycemic and hypoglycemic episodes. It is important to rotate injection sites to minimize lipodystrophy. Patients should also be counseled about the potential for insulin to cause weight gain and the need for a balanced diet and physical activity.